ReviewCancer reports (Hoboken, N.J.)2022

High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome.

Iosif Strouthos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.